Full data view for gene TSC2

The curator’s expert opinion on the classification of a variant, can be found in the
SUMMARY record. Regarding the classification, please note that where there are several
records of the same variant, the classification of that variant may differ depending on the
submitter’s conclusion.
Information The variants shown are described using the NM_000548.3 transcript reference sequence.

2 entries on 1 page. Showing entries 1 - 2.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/. _1_16i c.-106_1717-2210{0} r.? p.? - - Unknown ACMG pathogenic (dominant) g.2097990_2118247del g.2047989_2068246del NC_000016.9: g.2086101_2118247del - TSC2_001691 32147bp deletion; TSC2 exons 1-16 deleted + 11890bp upstream of TSC2; deletion starts upstream in NHERF2 intron 2, includes entire NTHL1 gene, and ends in TSC2 intron 16 PubMed: Ogorek, 2020 - - Germline ? - - - - DNA MLPA, SEQ, SEQ-NG-I Blood Targeted massive parallel sequencing, mean target coverage of 327× to 1614× (median 716×), MLPA TSC2 P337-B1 probe mix used, Genome sequencing also done, deletion confirmed by PCR across breakpoints, gel electrophoresis and Sanger sequencing TSC 01-028 PubMed: Ogorek, 2020 infant with drug resistant epilepsy; no history of TSC in the family; patient had first subclinical/clinical seizures at day 75 during the study F ? - - - - - - 1 Rosemary Ekong
+/+ _1_16i c.-106_1717-2210{0} r.? p.? - - Unknown - pathogenic (dominant) g.2097990_2118247del g.2047989_2068246del - - TSC2_001691 32147bp deletion; TSC2 exons 1-16 deleted + 11890bp upstream of TSC2; deletion ends in TSC2 intron 16; upstream deletion involves NTHL1 gene - - - SUMMARY record - - - - - - - - - - - - - - - - - - - - - - -
Legend   How to query  

Assessment of functional consequences - Our conclusions on the functional consequences of variants are based on the type of variant, results of in vitro functional tests (doi: 10.1002/humu.21451; doi: 10.1002/humu.22202; doi: 10.1002/humu.23963), population frequencies, output from in silico splice site prediction algorithms, and any clinical/family data available to us. We also have output from protein prediction programs in this database for comparison purposes and they are not considered in our assessment of pathogenicity. PolyPhen Predictions - Note that these results are from PolyPhen-2 and only the HumDiv classification is shown.


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.